BFC
IRD

Bedel Financial Consulting’s Opus Genetics IRD Stock Holding History

Bedel Financial Consulting’s Portfolio IRD Stock Details IRD Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		– Sell
-15,000
Closed -$68.3K – 321
2026
Q1 		$68.3K Hold
15,000
– – 0.01% 294
2025
Q4 		$30.1K Hold
15,000
– – ﹤0.01% 289
2025
Q3 		$24.8K Hold
15,000
– – ﹤0.01% 284
2025
Q2 		$14.1K Hold
15,000
– – ﹤0.01% 273
2025
Q1 		$14K Hold
15,000
– – ﹤0.01% 260
2024
Q4 		$18.1K Hold
15,000
– – ﹤0.01% 266
2024
Q3 		$19.6K Hold
15,000
– – ﹤0.01% 259
2024
Q2 		$22.9K Hold
15,000
– – ﹤0.01% 250
2024
Q1 		$30.1K Hold
15,000
– – ﹤0.01% 253
2023
Q4 		$45.1K Hold
15,000
– – 0.01% 242
2023
Q3 		$50.3K Hold
15,000
– – 0.01% 232
2023
Q2 		$65.1K Hold
15,000
– – 0.01% 237
2023
Q1 		$56.3K Hold
15,000
– – 0.01% 225
2022
Q4 		$53K Hold
15,000
– – 0.01% 226
2022
Q3 		$31K Buy
+15,000
New +$32.4K 0.01% 212

Other funds holding IRD

MFS
Miller Financial Services Marshall, Michigan $124M AUM 17.62% 1-Year Est. Return
JIR
James Investment Research Alpha, Ohio $984M AUM 36.03% 1-Year Est. Return
PFSRSONJ
Police & Firemen's Retirement System of New Jersey Trenton, New Jersey $13.3B AUM 45.46% 1-Year Est. Return
New York State Common Retirement Fund
New York State Common Retirement Fund Albany, New York $79.3B AUM 43.63% 1-Year Est. Return
KPWS
Kestra Private Wealth Services Austin, Texas $9.1B AUM 32.09% 1-Year Est. Return
FCCM
First City Capital Management Savannah, Georgia $206M AUM 26.13% 1-Year Est. Return
SO
STRS Ohio Columbus, Ohio $26.7B AUM 43.32% 1-Year Est. Return
HHCP
Hilton Head Capital Partners Hilton Head Island, South Carolina $198M AUM
FFA
Farther Finance Advisors San Francisco, California $12.8B AUM 26.53% 1-Year Est. Return
TWC
TD Waterhouse Canada Toronto, Ontario, Canada $38B AUM 39.14% 1-Year Est. Return

Bedel Financial Consulting's IRD Position: Q2 2026 in Review

Bedel Financial Consulting sold out of Opus Genetics (IRD) in Q2 2026, closing a stake of 15,000 shares — an estimated $68.3K sold.

Bedel Financial Consulting first reported a position in IRD in Q3 2022 and held it in 15 quarters. The position peaked at $68.3K in Q1 2026. 14 funds tracked by Wall St. Rank hold IRD as of Q2 2026.

  • Bedel Financial Consulting reported no remaining Opus Genetics position as of Q2 2026 after selling out during the quarter.
  • Bedel Financial Consulting sold 15,000 Opus Genetics shares in Q2 2026, an estimated $68.3K.
  • Bedel Financial Consulting first reported a position in Opus Genetics in Q3 2022 and held it in 15 quarters.
  • Bedel Financial Consulting's Opus Genetics position peaked at $68.3K in Q1 2026.
  • 14 funds tracked by Wall St. Rank held Opus Genetics as of Q2 2026.

Based on Bedel Financial Consulting's 13F filing for Q2 2026, filed 29 Jul 2026.